Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Alphabet Class A | 3.29% | $22.81M | $4.06T | 68.39% | 85 Outperform | |
| Apple | 2.34% | $16.21M | $3.77T | 8.71% | 79 Outperform | |
| Microsoft | 2.32% | $16.07M | $3.58T | 4.46% | 79 Outperform | |
| Johnson & Johnson | 2.19% | $15.19M | $548.64B | 48.68% | 78 Outperform | |
| RTX | 2.03% | $14.12M | $267.43B | 54.97% | 74 Outperform | |
| Novo Nordisk | 2.02% | $14.05M | $270.07B | -30.48% | 73 Outperform | |
| CH Robinson | 1.98% | $13.76M | $21.77B | 92.87% | 72 Outperform | |
| The Estée Lauder Companies | 1.97% | $13.64M | $41.30B | 34.78% | 56 Neutral | |
| Berkshire Hathaway B | 1.92% | $13.30M | $1.02T | 0.94% | 66 Neutral | |
| Rentokil Initial | 1.81% | $12.57M | $16.10B | 28.46% | 66 Neutral |